SCHEMBL8286383

SCHEMBL8286383

Cc1cc(OCC(F)(F)F)c2c(=O)cc(Nc3ccccc3)n(-c3ccccc3)c2n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE11A Q9HCR9 1/20 0.51
LMNA P02545 3/20 0.39
TDP1 Q9NUW8 2/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
PIK3CD O00329 1/20 0.38
PIK3R2 O00459 1/20 0.38
PIK3CG P48736 1/20 0.38
GSK3B P49841 4/20 0.37
P2RX7 Q99572 3/20 0.37
HPGD P15428 3/20 0.36
MAPK1 P28482 2/20 0.36
GAA P10253 2/20 0.36
NPSR1 Q6W5P4 2/20 0.35
KDM4E B2RXH2 1/20 0.35
ATM Q13315 1/20 0.35
POLB P06746 1/20 0.35
UGCG Q16739 1/20 0.35
GSK3A P49840 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8286395 0.86 PDE11A (0.44) PDE11ALMNATDP1MEN1KMT2A
SCHEMBL8286366 0.85 PDE11A (0.43) PDE11ALMNATDP1MEN1KMT2A
SCHEMBL8286379 0.85 PDE11A (0.43) PDE11ALMNATDP1MEN1KMT2A
SCHEMBL8287832 0.84 PDE11A (0.47) PDE11ALMNATDP1MEN1KMT2A
SCHEMBL8287893 0.83 PDE11A (0.44) PDE11ALMNATDP1L3MBTL1GSK3B
SCHEMBL8286416 0.83 PDE11A (0.42) PDE11ALMNATDP1MEN1KMT2A
SCHEMBL8287417 0.83 HTT (0.47) PDE11ALMNAL3MBTL1HPGDMAPK1
SCHEMBL5872270 0.82 PDE11A (0.44) PDE11ALMNATDP1MEN1KMT2A
SCHEMBL8286402 0.82 ALDH1A1 (0.43) PDE11ALMNAMEN1KMT2AHPGD
SCHEMBL8286377 0.82 PDE11A (0.45) PDE11ALMNATDP1GSK3BHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed